<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-23T07:05:18Z</responseDate><request verb="GetRecord" identifier="oai:www.repository.cam.ac.uk:1810/388252" metadataPrefix="uketd_dc">https://api.repository.cam.ac.uk/server/oai/request</request><GetRecord><record><header><identifier>oai:www.repository.cam.ac.uk:1810/388252</identifier><datestamp>2025-12-21T02:05:06Z</datestamp><setSpec>com_1810_219476</setSpec><setSpec>com_1810_256062</setSpec><setSpec>col_1810_219483</setSpec></header><metadata><uketd_dc:uketddc xmlns:uketd_dc="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:uketdterms="http://naca.central.cranfield.ac.uk/ethos-oai/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/ http://naca.central.cranfield.ac.uk/ethos-oai/2.0/uketd_dc.xsd">
   <dc:title>Co-regulation of the Smooth Muscle Cell Alternative Splicing Programme by the RNA-Binding Proteins RBPMS, RBFOX2, MBNL1, and QKI</dc:title>
   <dc:identifier xsi:type="dcterms:DOI">https://doi.org/10.17863/CAM.120680</dc:identifier>
   <dc:creator>Huang, Yuling</dc:creator>
   <uketdterms:advisor>Smith, Christopher</uketdterms:advisor>
   <dcterms:abstract>The phenotypic switching of vascular smooth muscle cells (VSMCs) from a contractile
/differentiated state to a synthetic/ proliferative state is a hallmark of many cardiovascular
diseases, driven in part by extensive alternative splicing (AS) regulation. RBPMS, a master
splicing regulator in differentiated VSMCs, is responsible for approximately 20% of AS
changes observed during dedifferentiation in PAC1 VSMCs (Nakagaki-Silva et al., 2019).
However, the cooperative and antagonistic relationships between RBPMS and other RNAbinding
proteins (RBPs) in this regulatory network remain unclear.
In this study, I investigated RBFOX2, MBNL1, and QKI as potential co-regulators of RBPMS in
VSMC AS regulation. RBFOX2 was identified as a key candidate due to enrichment of its
GCAUG binding motifs around RBPMS-regulated exons in positions suggesting cooperative
regulation. MBNL1 was selected for its physical interaction with RBPMS and overlapping
regulation of AS events, while QKI was selected as a potential antagonist of the RBPMSpromoted
splicing programme, promoting a more proliferative phenotype.
Using RNA-seq following RBP knockdowns, I identified distinct contributions of these RBPs
to the VSMC splicing programme. RBPMS, RBFOX2, and MBNL1 predominantly cooperated
to promote AS patterns associated with VSMC differentiation. In contrast, QKI exhibited
context-dependent regulatory effects, aligning with RBPMS in some cases while acting
antagonistically in others. Gene Ontology (GO) analysis confirmed that ASEs regulated by
RBPMS and its coregulatory RBPs are linked to key cellular processes involved in phenotype
switching. Knockdown RBPs also demonstrated distinct effects on cell morphology and
motility. Co-immunoprecipitation (Co-IP) assays demonstrated physical interactions
between RBPMS and RBFOX2, MBNL1, and QKI. In the case of RBPMS and RBFOX2 aromatic
residues in their intrinsically disordered domains were shown to be essential for both their physical interactions and for their splicing regulatory activities, suggesting that these two
proteins interact directly to regulate target splicing events.
These findings provide insights into the intricate networks of RBPs involved in AS regulation
during VSMC phenotypic plasticity, advancing our understanding of vascular remodelling
and offering new avenues for targeted therapeutic strategies in cardiovascular diseases.</dcterms:abstract>
   <uketdterms:institution>University of Cambridge</uketdterms:institution>
   <dcterms:issued>2025-01-31</dcterms:issued>
   <dc:type>Thesis</dc:type>
   <uketdterms:qualificationlevel>Doctoral</uketdterms:qualificationlevel>
   <uketdterms:qualificationname>Doctor of Philosophy (PhD)</uketdterms:qualificationname>
   <dc:language>eng</dc:language>
   <uketdterms:sponsor>The Cambridge Trust and China Scholarship Council</uketdterms:sponsor>
   <dcterms:isReferencedBy xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/handle/1810/388252</dcterms:isReferencedBy>
   <dc:identifier xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/bitstreams/6406105a-f354-415e-8b69-dfe945a4fad1/download</dc:identifier>
   <uketdterms:checksum xsi:type="uketdterms:MD5">42cdd900b6d31ec67355d0378deecdf1</uketdterms:checksum>
   <dcterms:license>https://www.repository.cam.ac.uk/bitstreams/3c214ded-2cc4-44c0-9c6d-18ae5cb7989d/download</dcterms:license>
   <uketdterms:checksum xsi:type="uketdterms:MD5">87eda9de84448d1f82354d60eee3eb5f</uketdterms:checksum>
   <dc:rights>http://purl.org/NET/rdflicense/allrightsreserved</dc:rights>
   <dc:subject>Vascular smooth muscle cells (VSMCs)</dc:subject>
   <dc:subject>Phenotypic switching</dc:subject>
   <dc:subject>Alternative splicing (AS)</dc:subject>
   <dc:subject>RNA-binding proteins (RBPs)</dc:subject>
   <dc:subject>RBPMS</dc:subject>
   <dc:subject>RBFOX2</dc:subject>
   <dc:subject>MBNL1</dc:subject>
   <dc:subject>QKI</dc:subject>
   <dc:subject>Cooperative regulation</dc:subject>
</uketd_dc:uketddc>
</metadata></record></GetRecord></OAI-PMH>